News

Annual vs. One-Time: Deconstructing State Drug Price Transparency Registration RequirementsIn Part 1 of our series, we introduced the critical role of state drug price transparency registrations in ensuring compliance. Now, we'll dive deeper into the two primary types...

In the increasingly complex world of drug price transparency, merely preparing your data for submission isn't enough. A foundational, yet often underestimated, element of compliance lies in understanding and managing the diverse state-specific registration processes....

In the intricate world of pharmaceutical and life sciences supply chains compliance is not merely a checkbox, it is the bedrock of your business's survival. While many companies operate under the dangerous illusion of safety the reality is stark. Non-compliance with...

The pharmaceutical and medical device industries are no strangers to dynamic regulatory landscapes. However, a recent and significant development from the Puerto Rico Department of Health (PR DOH) demands immediate attention from companies operating, or planning to...

For professionals in the life sciences and pharmaceutical space, staying on top of state licensing requirements can feel like an unending game of regulatory whack-a-mole. One day it’s a new renewal deadline in Maine, the next it’s a form update in Texas or a digital...

In the pharmaceutical industry, staying licensed is non-negotiable. A single lapse can halt operations, trigger audits, invite regulatory penalties, and compromise patient trust. Yet, in the rush to “automate everything,” many companies have fallen into a costly trap:...